cycloserine has been researched along with amikacin in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (8.33) | 18.7374 |
1990's | 1 (4.17) | 18.2507 |
2000's | 4 (16.67) | 29.6817 |
2010's | 15 (62.50) | 24.3611 |
2020's | 2 (8.33) | 2.80 |
Authors | Studies |
---|---|
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ | 1 |
Ali, MA; Choon, TS; Ismail, R; Kumar, RS; Wei, AC; Yoon, YK | 1 |
Danac, R; Mangalagiu, II | 1 |
Asís, SE; Buldain, GY; Muscia, GC | 1 |
Ali, MA; Choon, TS; Kanchithalaivan, S; Ponnuchamy, S; Ranjith Kumar, R | 1 |
Ashraf Ali, M; Choon, TS; Devi Bala, B; Muthusaravanan, S; Perumal, S | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E | 1 |
Ashraf Ali, M; Bharkavi, C; Muthusubramanian, S; Osman, H; Perumal, S; Vivek Kumar, S | 2 |
Baikova, IP; Giniyatullina, GV; Kataev, VE; Kazakova, OB; Lopatina, TV; Medvedeva, NI; Smirnova, IE | 1 |
da Silva Emery, F; de Melo, SMG; Fumagalli, F; Pavan, FR; Ribeiro, CM; Solcia, MC | 1 |
Barrio, JL; Pitchenik, AE; Rodriguez, JL | 1 |
Baird, B; Fauci, AS; Gill, V; Grimes, G; Lane, HC; Masur, H; Tuazon, C | 1 |
Furukawa, T; Komachi, H; Nagai, R; Saito, Y; Takewaki, S; Uchihara, T | 1 |
Kam, KM; Yip, CW | 1 |
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
Farnia, P; Khoshnood, K; Mansoori, SD; Masjedi, H; Masjedi, MR; Mirsaeidi, SM; Mohammadi, F; Pooramiri, MV; Rowhani-Rahbar, A; Tabarsi, P; Velayati, AA; Zahirifard, S | 1 |
Amiri, M; Baghaei, P; Caminero, JA; Chitsaz, E; Farnia, P; Kazempour, M; Mansouri, D; Marjani, M; Masjedi, MR; Shamaei, M; Tabarsi, P; Velayati, AA | 1 |
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S | 1 |
Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X | 1 |
Basdeo, SA; Cahill, C; Cox, DJ; Gogan, KM; Gordon, SV; Keane, J; O'Connell, F; O'Sullivan, J; Phelan, JJ | 1 |
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
1 review(s) available for cycloserine and amikacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cycloserine and amikacin
Article | Year |
---|---|
Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Female; Humans; Iran; Isoniazid; Male; Middle Aged; Ofloxacin; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2005 |
22 other study(ies) available for cycloserine and amikacin
Article | Year |
---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2010 |
A facile three-component [3+2]-cycloaddition for the regioselective synthesis of highly functionalised dispiropyrrolidines acting as antimycobacterial agents.
Topics: Anti-Bacterial Agents; Cycloaddition Reaction; High-Throughput Screening Assays; Microbial Sensitivity Tests; Pyrrolidines | 2013 |
Antimycobacterial activity of nitrogen heterocycles derivatives: bipyridine derivatives. Part III.
Topics: Antitubercular Agents; Heterocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Nitrogen; Pyridines | 2014 |
Design, synthesis and evaluation of acridine and fused-quinoline derivatives as potential anti-tuberculosis agents.
Topics: Acridines; Animals; Antitubercular Agents; Cell Line; Cyclization; Drug Design; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines | 2014 |
Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazolidinediones | 2014 |
Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation.
Topics: Antitubercular Agents; Benzopyrans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Naphthoquinones; Triazoles | 2014 |
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis.
Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant | 2016 |
A facile stereoselective synthesis of dispiro-indeno pyrrolidine/pyrrolothiazole-thiochroman hybrids and evaluation of their antimycobacterial, anticancer and AchE inhibitory activities.
Topics: Acetylcholinesterase; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholinesterase Inhibitors; Chromones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indenes; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2016 |
One-pot microwave assisted stereoselective synthesis of novel dihydro-2'H-spiro[indene-2,1'-pyrrolo-[3,4-c]pyrrole]-tetraones and evaluation of their antimycobacterial activity and inhibition of AChE.
Topics: Acetylcholinesterase; Antitubercular Agents; Cholinesterase Inhibitors; Crystallography, X-Ray; Drug Design; Enzyme Activation; Inhibitory Concentration 50; Microbial Sensitivity Tests; Microwaves; Molecular Conformation; Mycobacterium tuberculosis; Pyrroles; Stereoisomerism; Structure-Activity Relationship | 2017 |
Synthesis and antimycobacterial activity of triterpeni≿ A-ring azepanes.
Topics: Antitubercular Agents; Azepines; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triterpenes | 2018 |
Exploiting the furo[2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis.
Topics: Amination; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Furans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship | 2019 |
Pulmonary nocardiosis in the acquired immunodeficiency syndrome. Diagnosis with bronchoalveolar lavage and treatment with non-sulphur containing drugs.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Cycloserine; Drug Therapy, Combination; Humans; Male; Minocycline; Nocardia asteroides; Nocardia Infections; Pneumonia, Pneumocystis; Pulmonary Alveoli; Radiography; Respiratory Tract Infections; Therapeutic Irrigation | 1986 |
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Cycloserine; Drug Therapy, Combination; Humans; Isoniazid; Lactams, Macrocyclic; Mycobacterium avium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Sepsis | 1987 |
Successful treatment of atypical mycobacterial meningitis by fluoroquinolone.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Ethambutol; Humans; Injections, Spinal; Isoniazid; Male; Meningitis; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Ofloxacin; Polymerase Chain Reaction; Rifampin; Streptomycin | 1996 |
Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug Combinations; Ethionamide; Hong Kong; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Program Evaluation; Recurrence; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Clinical Protocols; Cycloserine; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Treatment Outcome; Tuberculosis, Pulmonary | 2010 |
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2014 |
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2016 |
The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG.
Topics: Amikacin; Antitubercular Agents; Bacterial Load; Cell Survival; Clofazimine; Cycloserine; Deferoxamine; Diarylquinolines; Drug Resistance, Bacterial; Drug Synergism; Gene Expression; Humans; Interferon-gamma; Interleukin-1beta; Interleukin-6; Iron; Iron Chelating Agents; Linezolid; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium bovis; Primary Cell Culture; Pyrazinamide | 2021 |
Use of Whole-Genome Sequencing to Predict
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |